Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer’s disease. Lancet. 2021;397:1577–90.
Article CAS PubMed PubMed Central Google Scholar
Gillis C, Montenigro P, Nejati M, Maserejian N. Estimating prevalence of early Alzheimer’s disease in the United States, accounting for racial and ethnic diversity. Alzheimers Dement. 2023;19:1841–8.
Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol. 2018;25:59–70.
Article CAS PubMed Google Scholar
2023 Alzheimer’s disease facts and figures. Alzheimers Dement. 2023;19:1598–695.
Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid beta-based therapy for Alzheimer’s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8:248.
Article CAS PubMed PubMed Central Google Scholar
Huang Z, Jordan JD, Zhang Q. Myelin pathology in Alzheimer’s disease: potential therapeutic opportunities. Aging Dis. 2023;15(2):698–713.
Cummings J, Osse AML, Cammann D, Powell J, Chen J. Anti-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease. BioDrugs. 2024;38:5–22.
Article CAS PubMed Google Scholar
Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Alzheimer’s disease drug development pipeline: 2023. Alzheimers Dement (N Y). 2023;9:e12385.
Ibrahim MM, Gabr MT. Multitarget therapeutic strategies for Alzheimer’s disease. Neural Regen Res. 2019;14:437–40.
Article CAS PubMed PubMed Central Google Scholar
Albertini C, Salerno A, de SenaMurteira Pinheiro P, Bolognesi ML. From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology. Med Res Rev. 2021;41:2606–33.
Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40:516–33.
Salehpour F, Mahmoudi J, Kamari F, Sadigh-Eteghad S, Rasta SH, Hamblin MR. Brain photobiomodulation therapy: a narrative review. Mol Neurobiol. 2018;55:6601–36.
Article CAS PubMed PubMed Central Google Scholar
Hamblin MR, Salehpour F. Photobiomodulation of the brain: shining light on Alzheimer’s and other neuropathological diseases. J Alzheimers Dis. 2021;83:1395–7.
Article CAS PubMed Google Scholar
Cardoso FDS, Gonzalez-Lima F, Gomes da Silva S. Photobiomodulation for the aging brain. Ageing Res Rev. 2021;70:101415.
Article CAS PubMed Google Scholar
Enengl J, Hamblin MR, Dungel P. Photobiomodulation for Alzheimer’s disease: translating basic research to clinical application. J Alzheimers Dis. 2020;75:1073–82.
Article PubMed PubMed Central Google Scholar
Hamblin MR. Shining light on the head: Photobiomodulation for brain disorders. BBA Clin. 2016;6:113–24.
Article PubMed PubMed Central Google Scholar
Yang L, Wu C, Parker E, Li Y, Dong Y, Tucker L, et al. Non-invasive photobiomodulation treatment in an Alzheimer disease-like transgenic rat model. Theranostics. 2022;12:2205–31.
Article CAS PubMed PubMed Central Google Scholar
Blivet G, Relano-Gines A, Wachtel M, Touchon J. A randomized, double-blind, and sham-controlled trial of an innovative brain-gut photobiomodulation therapy: safety and patient compliance. J Alzheimers Dis. 2022;90:811–22.
Article CAS PubMed Google Scholar
Baik JS, Lee TY, Kim NG, Pak K, Ko SH, Min JH, et al. Effects of photobiomodulation on changes in cognitive function and regional cerebral blood flow in patients with mild cognitive impairment: a pilot uncontrolled trial. J Alzheimers Dis. 2021;83:1513–9.
Article CAS PubMed Google Scholar
Saltmarche AE, Naeser MA, Ho KF, Hamblin MR, Lim L. Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report. Photomed Laser Surg. 2017;35:432–41.
Article PubMed PubMed Central Google Scholar
Gordon LC, Johnstone DM. Remote photobiomodulation: an emerging strategy for neuroprotection. Neural Regen Res. 2019;14:2086–7.
Article PubMed PubMed Central Google Scholar
Hamblin MR. Photobiomodulation for Alzheimer’s disease: has the light dawned? Photonics. 2019;6(3):77.
Article CAS PubMed PubMed Central Google Scholar
Monteiro F, Carvalho O, Sousa N, Silva FS, Sotiropoulos I. Photobiomodulation and visual stimulation against cognitive decline and Alzheimer’s disease pathology: a systematic review. Alzheimers Dement (N Y). 2022;8:e12249.
Lee TL, Ding Z, Chan AS. Can transcranial photobiomodulation improve cognitive function? A systematic review of human studies. Ageing Res Rev. 2023;83:101786.
Tao L, Liu Q, Zhang F, Fu Y, Zhu X, Weng X, et al. Microglia modulation with 1070-nm light attenuates Abeta burden and cognitive impairment in Alzheimer’s disease mouse model. Light Sci Appl. 2021;10:179.
Article CAS PubMed PubMed Central Google Scholar
Wang M, Cao J, Amakye WK, Gong C, Li Q, Ren J. Mid infrared light treatment attenuates cognitive decline and alters the gut microbiota community in APP/PS1 mouse model. Biochem Biophys Res Commun. 2020;523:60–5.
Article CAS PubMed Google Scholar
Bowen R, Arany PR. Use of either transcranial or whole-body photobiomodulation treatments improves COVID-19 brain fog. J Biophotonics. 2023;16:e202200391.
Fitzmaurice B, Heneghan NR, Rayen A, Soundy A. Whole-body photobiomodulation therapy for chronic pain: a protocol for a feasibility trial. BMJ Open. 2022;12:e060058.
Article PubMed PubMed Central Google Scholar
Gordon LC, Martin KL, Torres N, Benabid AL, Mitrofanis J, Stone J, et al. Remote photobiomodulation targeted at the abdomen or legs provides effective neuroprotection against parkinsonian MPTP insult. Eur J Neurosci. 2023;57:1611–24.
Article CAS PubMed PubMed Central Google Scholar
Kim B, Brandli A, Mitrofanis J, Stone J, Purushothuman S, Johnstone DM. Remote tissue conditioning - an emerging approach for inducing body-wide protection against diseases of ageing. Ageing Res Rev. 2017;37:69–78.
Blivet G, Meunier J, Roman FJ, Touchon J. Neuroprotective effect of a new photobiomodulation technique against Abeta(25–35) peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested. Alzheimers Dement (N Y). 2018;4:54–63.
Chen Q, Wu J, Dong X, Yin H, Shi X, Su S, et al. Gut flora-targeted photobiomodulation therapy improves senile dementia in an Ass-induced Alzheimer’s disease animal model. J Photochem Photobiol B. 2021;216:112152.
Article CAS PubMed Google Scholar
Wu X, Shen Q, Chang H, Li J, Xing D. Promoted CD4(+) T cell-derived IFN-gamma/IL-10 by photobiomodulation therapy modulates neurogenesis to ameliorate cognitive deficits in APP/PS1 and 3xTg-AD mice. J Neuroinflammation. 2022;19:253.
Article CAS PubMed PubMed Central Google Scholar
Karu TI, Pyatibrat LV, Kalendo GS. Photobiological modulation of cell attachment via cytochrome c oxidase. Photochem Photobiol Sci. 2004;3:211–6.
Article CAS PubMed Google Scholar
AhamedBasha A, Mathangi DC, Shyamala R. Effect of LED photobiomodulation on fluorescent light induced changes in cellular ATPases and Cytochrome c oxidase activity in Wistar rat. Lasers Med Sci. 2016;31:1803–9.
Wikstrom M, Krab K, Sharma V. Oxygen activation and energy conservation by cytochrome c oxidase. Chem Rev. 2018;118:2469–90.
Article CAS PubMed PubMed Central Google Scholar
Cooper CE, Cope M, Springett R, Amess PN, Penrice J, Tyszczuk L, et al. Use of mitochondrial inhibitors to demonstrate that cytochrome oxidase near-infrared spectroscopy can measure mitochondrial dysfunction noninvasively in the brain. J Cereb Blood Flow Metab. 1999;19:27–38.
Article CAS PubMed Google Scholar
de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22(3):7000417.
留言 (0)